RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GlaxoSmithKline Stock

GlaxoSmithKline ROA 2024

GlaxoSmithKline ROA

0.08

Ticker

GSK.L

ISIN

GB0009252882

WKN

940561

In 2024, GlaxoSmithKline's return on assets (ROA) was 0.08, a -66.41% increase from the 0.25 ROA in the previous year.

GlaxoSmithKline Aktienanalyse

What does GlaxoSmithKline do?

GlaxoSmithKline PLC is a globally leading pharmaceutical company headquartered in London, UK. The company's history dates back to 1873 when the Burroughs Wellcome & Co firm was founded. In 2000, the company merged with Glaxo Wellcome to form the current GlaxoSmithKline PLC. GlaxoSmithKline's business model is to provide medical solutions for various diseases and health problems. The company heavily invests in research and development to develop new drugs and vaccines. It collaborates closely with government agencies, hospitals, doctors, and patient organizations to ensure better access to its products. The company is divided into three different divisions: Pharma, Vaccines, and Consumer Healthcare. The Pharma division is the largest and includes areas such as oncology, immunology, neuroscience, respiratory, and infectious diseases. GlaxoSmithKline is a leader in HIV treatment and is also active in the development of cancer drugs. The Vaccines division of GlaxoSmithKline is also very large and includes vaccines against various infectious diseases such as pneumococcus, influenza, and meningitis. It is also working on the development of vaccines against COVID-19. GlaxoSmithKline's Consumer Healthcare division includes products such as Sensodyne, Voltaren, Nicotinell, and Aquafresh. These products operate in the areas of oral health, pain relief, and smoking cessation. The focus is on a wide range of over-the-counter products available in pharmacies and supermarkets. An example of an important product of GlaxoSmithKline is the malaria vaccine developed in collaboration with the University of Oxford. The vaccine has the potential to save millions of lives in Africa. Currently, the vaccine is being tested in several African countries. GlaxoSmithKline PLC has also faced some controversies in the past, particularly related to the marketing of antidepressants. However, the company has taken measures to increase the transparency of its practices and operate ethically. Overall, GlaxoSmithKline is a significant pharmaceutical company that offers a wide range of medical products and solutions. It heavily invests in research and development to develop new products that can improve people's lives. The company also adopts an ethical approach in its business and advocates for better access to its products. GlaxoSmithKline ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding GlaxoSmithKline's Return on Assets (ROA)

GlaxoSmithKline's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing GlaxoSmithKline's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider GlaxoSmithKline's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in GlaxoSmithKline’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about GlaxoSmithKline stock

What is the Return on Assets (ROA) of GlaxoSmithKline this year?

The Return on Assets (ROA) of GlaxoSmithKline is 0.08 undefined this year.

What was the ROA of GlaxoSmithKline compared to the previous year?

The ROA of GlaxoSmithKline has increased by -66.41% compared to the previous year.

What consequences do high ROA have for investors of GlaxoSmithKline?

A high ROA is advantageous for investors of GlaxoSmithKline, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in GlaxoSmithKline?

A low ROA can be unfavorable for investors of GlaxoSmithKline as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of GlaxoSmithKline affect the company?

An increase in ROA of GlaxoSmithKline can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of GlaxoSmithKline impact the company?

A reduction in the ROA of GlaxoSmithKline can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of GlaxoSmithKline?

Some factors that can influence the ROA of GlaxoSmithKline include revenue, operating costs, asset structure, and industry average.

Why is the ROA of GlaxoSmithKline important for investors?

The ROA of GlaxoSmithKline is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can GlaxoSmithKline take to improve ROA?

To improve ROA, GlaxoSmithKline can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does GlaxoSmithKline pay?

Over the past 12 months, GlaxoSmithKline paid a dividend of 0.56 GBP . This corresponds to a dividend yield of about 3.82 %. For the coming 12 months, GlaxoSmithKline is expected to pay a dividend of 1.04 GBP.

What is the dividend yield of GlaxoSmithKline?

The current dividend yield of GlaxoSmithKline is 3.82 %.

When does GlaxoSmithKline pay dividends?

GlaxoSmithKline pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of GlaxoSmithKline?

GlaxoSmithKline paid dividends every year for the past 26 years.

What is the dividend of GlaxoSmithKline?

For the upcoming 12 months, dividends amounting to 1.04 GBP are expected. This corresponds to a dividend yield of 7.14 %.

In which sector is GlaxoSmithKline located?

GlaxoSmithKline is assigned to the 'Health' sector.

Wann musste ich die Aktien von GlaxoSmithKline kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GlaxoSmithKline from 10/10/2024 amounting to 0.15 GBP, you needed to have the stock in your portfolio before the ex-date on 8/15/2024.

When did GlaxoSmithKline pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of GlaxoSmithKline in the year 2023?

In the year 2023, GlaxoSmithKline distributed 0.67 GBP as dividends.

In which currency does GlaxoSmithKline pay out the dividend?

The dividends of GlaxoSmithKline are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The GlaxoSmithKline stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von GlaxoSmithKline

Our stock analysis for GlaxoSmithKline Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GlaxoSmithKline Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.